Latest News

Insiders who purchased WS-SK Target Group Limited ( HKG:8427 ) shares in the past 12 months are unlikely to be deeply...

Mr D.I.Y. Group (M) Berhad's ( KLSE:MRDIY ) price-to-earnings (or "P/E") ratio of 23.5x might make it look like a...

Key Insights Significantly high institutional ownership implies CSC Financial's stock price is sensitive to their...

Key Insights Insiders appear to have a vested interest in INTLOOP's growth, as seen by their sizeable ownership...

While Wrkr Ltd ( ASX:WRK ) shareholders have had a good week with the stock up 13%, insiders can't say the same having...

THE CODI Co.,LTD.'s ( KOSDAQ:224060 ) price-to-sales (or "P/S") ratio of 0.5x might make it look like a buy right now...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Most readers would already be aware that Ingdan's (HKG:400) stock increased significantly by 17% over the past three...

With a price-to-earnings (or "P/E") ratio of 6.6x China Ludao Technology Company Limited ( HKG:2023 ) may be sending...

While Hana Materials Inc. ( KOSDAQ:166090 ) might not have the largest market cap around , it saw a significant share...

Today we're going to take a look at the well-established Geely Automobile Holdings Limited ( HKG:175 ). The company's...

Key Insights Hansun Engineering's significant public companies ownership suggests that the key decisions are influenced...

Civmec Limited's ( ASX:CVL ) price-to-earnings (or "P/E") ratio of 19.1x might make it look like a buy right now...

Sheng Siong Group (SGX:OV8) has had a great run on the share market with its stock up by a significant 24% over the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Sheffield Resources Limited ( ASX:SFX ) is possibly approaching a major achievement in its business, so we would like...

Omeros (OMER) drew fresh investor attention after the U.S. Food and Drug Administration approved YARTEMLEA for hematopoietic stem cell transplant associated thrombotic microangiopathy, and the company is preparing a U.S. launch and related reimbursement infrastructure. See our latest analysis for Omeros. The FDA approval appears to be the main backdrop for recent price action, with a 30 day share price return of 50.97% and a 90 day share price return of 268.92%. Meanwhile, the 1 year total...

When close to half the companies operating in the Auto Components industry in Hong Kong have price-to-sales ratios (or...

Key Insights Significant control over SITC International Holdings by private companies implies that the general public...

Key Insights The considerable ownership by public companies in M.I.TECHLtd indicates that they collectively have a...

Zhixin Group Holding Limited ( HKG:2187 ) shares have continued their recent momentum with a 40% gain in the last month...

There are a few key trends to look for if we want to identify the next multi-bagger. Typically, we'll want to notice a...

Persol Holdings Co.,Ltd.'s ( TSE:2181 ) price-to-earnings (or "P/E") ratio of 16.8x might make it look like a sell...

Most readers would already be aware that Ebrains' (TSE:6599) stock increased significantly by 22% over the past three...